Drug: veletri (epoprostenol) 1.5MG, vial, INJ, NDC #66215-0402-01 - buld funding for FY2018
Ended Awarded Last action
- Contract number
- VA26018J2277
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $61,679
Award facts
- Contract value 100% obligated
- $61,678.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,321 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $65,000 |
Quick answers
Who was awarded contract VA26018J2277?
VA26018J2277 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2017.
How much is contract VA26018J2277 worth?
The government has obligated $61,679 on VA26018J2277.
Is contract VA26018J2277 an order under another contract?
Yes. VA26018J2277 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26018J2277 competed?
The extent of competition for VA26018J2277 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award